Aysha Arshad is a Cardiology physician. OpenAlex indexes 63 publications with 2,837 citations (h-index 23).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
8100 Ashton Ave Ste 200
Manassas, VA 201095688
Telephone
877-415-4116Provider last certified this registry record 10 Jan 2024.
Industry payments
40 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202536 payments
- Abbott LaboratoriesProgram year202539 payments
- AstraZeneca Pharmaceuticals LPProgram year20256 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
69.3%Beta blocker18.9%Metoprolol Succinate49%Carvedilol28%Metoprolol Tartrate17%Sotalol4%Atenolol3%Part D<11 patientsAntiarrhythmic14.2%Dofetilide42%Amiodarone Hcl31%Flecainide Acetate24%Multaq4%Part D<11 patients+ 13 more classes in this area
Blood & clotting
26.1%Factor Xa inhibitor23.8%Eliquis77%Xarelto23%Part D≥140 patientsP2Y12 inhibitor1.8%Clopidogrel100%Part D≥18 patients+ 1 more class in this area
Metabolism & gastrointestinal
3.6%SGLT2 inhibitor2.8%Jardiance68%Farxiga32%Part D<11 patientsPotassium supplement0.8%Potassium Chloride100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Unilateral Task, Bilateral Response: An Acquired Movement Disorder in a Child With Chiari Malformation Type III and Syringomyelia
Annals of the Child Neurology Society
2025 - Correlation of ER, PR, nodal status & NPI with oncotype recurrence score in older women with breast cancer. Was there any impact on offer of chemotherapy?
European Journal of Surgical Oncology
2022 - FEASIBILITY AND ECONOMIC ANALYSIS OF OFFICE BASED IMPLANTABLE CARDIAC MONITOR INSERTION. ABBOTT CONFIRM RX OFFICE STUDY
Journal of the American College of Cardiology
2021 - Analysis of Tuberculosis Meningitis Pathogenesis, Diagnosis, and Treatment
Journal of Clinical Medicine
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”